Papers: 10.1177/0036933020951926
https://doi.org/10.1177/0036933020951926
Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study
Cited by: 12
Author(s): Khurram Khan, Hamish Reed-Embleton, Jen Lewis, Pamela Bain, Sajid Mahmud
Published: about 6 years ago
Software Mentions 1
bioconductor: SIMD
Statistical Inferences with MeDIP-seq Data (SIMD) to infer the methylation level for each CpG sitePapers that mentioned: 83
Very Likely Science (100)